Key takeaways
Semaglutide (Wegovy) and phentermine (Adipex-P) are both prescription weight management medications, but they have important differences. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, while phentermine is a sympathomimetic stimulant. Semaglutide is FDA-approved for long-term weight management in adults and children aged 12 and older meeting certain body mass index (BMI) criteria. It also lowers the risk of heart problems in adults with heart disease. Phentermine, on the other hand, is approved for short-term weight management in adults aged 17 and older. Semaglutide is administered as a weekly subcutaneous injection, whereas phentermine is taken orally once daily. Phentermine is available in various forms, including tablets, capsules, and orally disintegrating tablets, and is available as a lower-cost generic. Common side effects of semaglutide include nausea and diarrhea, while phentermine may cause dry mouth, a fast heart rate, and trouble sleeping. Phentermine is a controlled substance due to its potential for misuse and dependence, but semaglutide is not.
